Contact Us
INNOGLY INNOGLY INNOGLY INNOGLY
Navigation
  • About us
    • COST Action
    • Network members
    • Scientific Outputs
      • Scientific Publications
      • Abstracts from Events
  • News
  • Events
  • Working Groups
    • Development and Cancer
    • Autophagy
    • Immunity
    • GAGs
  • STSM
    • STSM information
    • STSM proposal
    • STSM evaluation
    • Awarded STSMs
  • ITC Grants
  • Training Schools

Logged out

Lost Password?

News

Training School on the Conjugation of Glycans onto Nanomaterials
The COST action "INNOGLY" (Innovation with glycans: new frontiers from ...
Read More
Glycosaminoglycan Interaction Networks and Databases
The article GLYCOSAMINOGLYCAN INTERACTION NETWORKS AND DATABASES , by Sylvie Ricard Blum and ...
Read More
INNOGLY Annual Meeting 2022 (4-6 May Lugano)
4-6 May 2022, Lugano, Switzerland The Annual Meeting of the INNOGLY ...
Read More
Exploring the Multifaceted Roles of Glycosaminoglycans (GAGs): Special Issue Reprint
Read More
GlycosAminoGlycans: What remains to be solved?
  Scientific and Organizing Committee: Dragana Nikitovic & Serge Perez Topical organizing ...
Read More

INNOGLY WG2 minisymposium: Autophagy

INNOGLY WG2 minisymposium

June 21, 3 pm – 5 pm Central European Time

 

Keynote at 3 pm CET

David Sleat, Associate Professor, Center of Advanced Biotechnology and Medicine, Rutgers University, New Jersey, USA

Lysosomal proteomics and human disease

Examples of publications by David Sleat:

Analysis of Brain and Cerebrospinal Fluid from Mouse Models of the Three Major Forms of Neuronal Ceroid Lipofuscinosis Reveals Changes in the Lysosomal Proteome.

Sleat DE, Wiseman JA, El-Banna M, Zheng H, Zhao C, Soherwardy A, Moore DF, Lobel P. Mol Cell Proteomics. 2019 Nov;18(11):2244-2261. doi: 10.1074/mcp.RA119.001587.

 

Inducible transgenic expression of tripeptidyl peptidase 1 in a mouse model of late-infantile neuronal ceroid lipofuscinosis.

Nemtsova Y, Wiseman JA, El-Banna M, Lobel P, Sleat DE. PLoS One. 2018 Feb 6;13(2):e0192286. doi: 10.1371/journal.pone.0192286. eCollection 2018.

 

 

Talks by INNOGLY members, 4 – 5 pm CET:

Massimo Aureli, University of Milan, Italy:

Involvement of lysosomal impairment in the onset of neuronal damage

 

Ole Kristian Greiner Tollersrud, Arctic University of Norway, Tromso:

Trimming of N-glycans in the lysosomes: A novel processing pathway

 

Mattan Hurevich and Shlomo Yitzchaik, The Hebrew University of Jerusalem, Israel:

Studying glycan interactions using electrochemical impedance spectroscopy

 

 

Register to the minisymposium by June 10 to:

eeva-liisa.eskelinen@utu.fi.

June 2, 2021

Events

Training School on the Conjugation of Glycans onto Nanomaterials
The COST action "INNOGLY" (Innovation with glycans: new frontiers from ...
Read More
WORKSHOP “Neuroglycoproteins in Health and Disease” 24-25 March 2022 Alicante (Spain)
Read More
INNOGLY Annual Meeting 2022 (4-6 May Lugano)
4-6 May 2022, Lugano, Switzerland The Annual Meeting of the INNOGLY ...
Read More

Follow us on Twitter


Follow INNOGLY

Twitter Timeline

RT @derda_lab: Checkout our #MachineLearning paper based on #NeuralNetworks that can predict protein-glycan interactions now out on @Chemic…

RT @bmmc_9: We are pleased to announce that Prof. Roberto Adamo will give a talk on Microbial Glycans in Vaccines. Follow him. Don’t miss t…

RT @ACSCentSci: #ICYMI #glycotime

Research by Jerry Turnbull & team @CarboKeele @LivUni

Synthetic Heparan Sulfate Mimetic Pixatimod (PG54…

RT @CarolynBertozzi: @AsAshraf123321 And in the clinic! Check out E-602 from @Palleon_Pharma

https://t.co/95PPcHwpSD

RT @RobertoAdamo10: Finally out this exciting review in collaboration with Prof. Codèe on synthetic glycans to improve glycoconjugate vacci…

POLICY STATEMENT:

Biomedicine and Molecular Biosciences Action CA18103 is funded by COST, which is supported by the EU Framework Programme Horizon 2020.

COST Action CA18103

© Copyright 2022. All Rights Reserved | Powered by innogly.eu | Designed by AWA
  • Imprint
  • /
  • Privacy policy
  • /
  • Cookie Policy (EU)
  • /
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
Preferences
{title} {title} {title}